Call for Open Pharma Access | GenomeWeb

Cory Doctorow argues at The Guardian that all, not just publicly funded, pharmaceutical research should be made open access. Many people, he says, agree that all publicly funded research should be available to the public — the main argument being that since the public funded it, they should be able to see the result. But Doctorow goes a step further.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.